Real-time enrollment status for this upper tract urothelial cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 8:45 PM UTC
| NCT Number | NCT06774131 |
| Recruiting Status | Recruiting |
| Condition | Upper Tract Urothelial Cancer |
| Phase | PHASE3 |
| Target Enrollment | 70 participants |
| Active Locations | 25 sites in the US |
| Sponsor | UroGen Pharma Ltd. |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of July 16, 2026: Clinical trial NCT06774131 is currently recruiting participants. This phase3 study for upper tract urothelial cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by UroGen Pharma Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06774131 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06774131 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.